PPrivate Fund Data
CompaniesFundsPeopleRankingsScreener

Redmile Biopharma Investments II, L.P.

Venture Capital FundFund ID 805-9153149946Delaware, United States
Gross assets
$661M
Min. investment
$5M
Beneficial owners
140
Size rank
Top 11%
Audited
Yes
Structure
Standalone

About this fund

Redmile Biopharma Investments II, L.P. is a venture capital fund managed by Redmile Group, LLC. The fund reports $661 million in gross assets, placing it among the top 11% of private funds by size. The stated minimum investment is $5 million. Its financial statements are audited annually. Private funds are not required to publicly disclose returns; Form ADV reports assets, structure, and service providers, shown above.

Fund details

Fund ID805-9153149946
Fund typeVenture Capital Fund
3(c)(1) exclusionNo
3(c)(7) exclusionYes
Master fundNo
Feeder fundNo
Fund of fundsNo
Relies on exemption from registrationYes
Annual auditYes
Prepared per GAAPYes
Sub-advisedNo
% of assets independently valued40%

Other funds from this manager

FundTypeGross assets
Redco II Master Fund, L.P.Hedge$1.56B
Redmile Biopharma Investments III, L.P.Private Equity$1.13B
Redmile Capital Offshore II Master Fund, Ltd.Hedge$738.2M
See all 17 funds from this manager — unlock the full record.
Join to unlock · $37/mo

Frequently asked questions

How large is Redmile Biopharma Investments II, L.P.?

Redmile Biopharma Investments II, L.P. reports $661 million in gross assets, among the top 11% of private funds by size.

What is the minimum investment for Redmile Biopharma Investments II, L.P.?

The stated minimum investment is $5 million.

Who manages Redmile Biopharma Investments II, L.P.?

Redmile Biopharma Investments II, L.P. is managed by Redmile Group, LLC.

Does Redmile Biopharma Investments II, L.P. disclose returns?

No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.

Manager

R
Larkspur, CA

Service providers

Prime broker
Administrator

Reported gross assets

$661M▲ 1%
Mar '25 — $657.6MApr '25 — $657.6MMay '25 — $657.6MJun '25 — $657.6MJul '25 — $657.6MAug '25 — $657.6MSep '25 — $657.6MOct '25 — $657.6MNov '25 — $657.6MDec '25 — $657.6MJan '26 — $657.6MFeb '26 — $657.6MMar '26 — $661MApr '26 — $661MMay '26 — $661MJun '26 — $661M
Mar '25Form ADV, monthlyJun '26

How this fund compares

Gross assetsTop 11%
Larger than 89% of 67,041 private funds
Gross assets vs Venture Capital FundsTop 5%
Larger than 95% of 5,217 venture capital funds
Minimum investmentTop 17%
Higher than 83% of funds reporting a minimum

Investor base

Adviser & related persons7%
Funds of funds19%
Non-U.S. persons46%
Share of the fund's beneficial ownership reported on Form ADV. Categories can overlap.